CLU and colorectal cancer: Notably, several significantly altered proteins, including APOA4, CLU, and SAA4, have previously been reported as potential biomarkers for colorectal cancer (Hlavca et al., 2024; Urbiola-Salvador et al., 2024; Zhu et al., 2024).